Appropriate management of moyamoya syndrome associated with Graves' disease is undetermined because of the rarity of this combination. Patients tend to present with cerebrovascular events such as transient ischemic attack (TIA) in a thyrotoxic state, which is relieved by proper antithyroid therapy. Four patients with moyamoya syndrome associated with Graves' disease were successfully treated with revascularization surgery on 5 hemispheres among 58 consecutive patients (2-62 years old, mean 34.4 years) with moyamoya disease in 80 hemispheres treated from March 2004 to May 2007. Three patients presented with TIA, and one patient presented with intracerebral hemorrhage. Three patients were thyrotoxic at the onset of the cerebrovascular events. All patients underwent revascularization surgery after normalization of thyroid function. Euthyroid state was strictly maintained perioperatively. One patient developed symptomatic cerebral hyperperfusion, which was resolved by blood pressure control. Postoperative courses of the other patients were uneventful, and all 4 patients have remained neurologically stable after discharge. Cerebrovascular reconstruction surgery is a successful treatment option for moyamoya syndrome associated with Graves' disease. Timing of surgery during the euthyroid state and perioperative management considering the thyroid function and the cerebral hemodynamic change are the keys to successful surgical treatment.
Introduction
Moyamoya disease is a progressive, occlusive cerebrovascular disease with unknown etiology characterized by bilateral steno-occlusive changes at the terminal portion of the internal carotid artery and abnormal vascular network at the base of the brain. 18 ) Quasi-moyamoya disease or moyamoya syndrome is the rarely observed characteristic moyamoya vasculopathy associated with conditions such as sickle cell disease, Down's syndrome, and neurofibromatosis type 1. 17) Several cases have been reported of the coexistence of moyamoya vasculopathy and Graves' disease, which is a femaledominant autoimmune thyroid disease causing hyperthyroidism. [5] [6] [7] 9, 10, 12, 13, 16, [19] [20] [21] Surgical revascularization for moyamoya disease prevents cerebral ischemic events by improving cerebral blood flow (CBF), and superficial temporal arterymiddle cerebral artery (STA-MCA) anastomosis with or without indirect pial synangiosis is generally used as the standard surgical treatment. 1) Application of this revascularization surgery to the treatment of moyamoya syndrome associated with Graves' disease is still undetermined because of the rarity of this combination. Ischemic symptoms may be reversible after the medical treatment of hyperthyroidism.
Here, we review 4 cases of moyamoya vasculopathy and Graves' disease successfully treated by revascularization surgery, focusing on perioperative management.
Materials and Methods
A total of 58 consecutive patients (2- had associated Graves' disease preoperatively, and were strictly followed up after surgery in our institutes. All 4 patients underwent STA-MCA anastomosis with encephalo-duro-myo-synangiosis (EDMS) and dural pedicle insertion 14) during the euthyroid state. Surgical criteria for moyamoya disease in our institute include presence of ischemic symptom, apparent hemodynamic compromise, activity of daily living better than modified Rankin scale 2, and absence of major cerebral infarction. Preoperative CBF and cerebral hemodynamic reserve capacity (CVR) were assessed using a stimulated CBF study with or without acetazolamide loading using N-isopropyl-p-[ 123 I]iodoamphetamine single-photon emission computed tomography ( 123 I-IMP SPECT). Postoperative CBF was routinely measured by 123 I-IMP SPECT 1 and 7 days after surgery. Magnetic resonance (MR) imaging and MR angiography were performed 2 and 8 days after surgery. Graves' disease was suspected when the patients showed typical clinical symptoms such as bilateral exophthalmos, diffuse goiter or dermopathy at initial presentation, and the diagnosis was made by an endocrinologist. In all 4 patients, levels of thyroid-stimulating hormone, free triiodothyronine (T3), and free thyroxine (T4) were tested at initial presentation to our hospital and in the perioperative period.
Results
The clinical features of the 4 Japanese patients (1 male and 3 females) aged from 34 to 55 years (mean 41.8 years) are summarized in Table 1 . All patients initially presented with transient ischemic attack (TIA). Three patients (Cases 2, 3, and 4) presented with TIA and one patient (Case 1) presented with intracerebral hemorrhage. Two patients (Cases 2 and 4) were diagnosed with moyamoya disease and Graves' disease at the same time at the first visit. Case 1 had been diagnosed with moyamoya disease based on TIA prior to the diagnosis of Graves' disease, and presented with intracerebral hemorrhage 10 years after the initial diagnosis of moyamoya disease. Case 3 had been diagnosed with Graves' disease 30 years prior to the diagnosis of moyamoya disease based on progressive TIA.
Thyroid function for each patient is summarized in Table 2 . Three of the 4 patients (Cases 2, 3, and 4) presented with thyrotoxic crisis, and one patient (Case 1) with moderate hyperthyroidism (Table 2) . Hyperthyroidism was treated with thiamazole for 2 Moyamoya Syndrome Associated With Graves' Disease to 3 months in all patients. The frequency of cerebral ischemic symptoms decreased after the antithyroid treatment. STA-MCA anastomosis was performed when the patients were euthyroid (Table 2 ). Antithyroid medications were restarted from the next day after surgery, and euthyroid was maintained during perioperative period in all patients.
The preoperative neuroimaging findings are summarized in Table 1 . One patient (Case 1) had intracerebral hemorrhage at the right caudate nucleus with intraventricular hematoma on computed tomography. The other 3 patients (Cases 2, 3, and 4) had some sort of ischemic change including previous cerebral infarction (Case 2) on MR imaging. Three of the 4 patients (Cases 1, 2, and 4) had bilateral stenoocclusive changes on cerebral angiography, and one patient (Case 3) had unilateral lesions. All patients had decreased CBF and significantly impaired CVR on 123 I-IMP SPECT.
Revascularization surgery was performed for the 5 affected hemispheres; unilateral in 3 patients (Cases 1, 3, and 4) and bilateral for 1 patient (Case 2). Second revascularization was performed 6 months after the initial surgery in Case 2. Postoperative SPECT revealed increase in CBF in the side of revascularization in all patients ( Table 1 ). The patency of STA-MCA bypass was confirmed in all patients by postoperative MR angiography. Postoperative MR imaging showed no ischemic or hemorrhagic complications.
One patient (Case 2) complained of frequent headaches on postoperative day 3, and developed transient fluctuating aphasia on postoperative day 5. These symptoms were considered to be due to cerebral hyperperfusion based on the postoperative CBF analysis and blood pressure dependency of the symptom. Intensive blood pressure control by nicardipine relieved these symptoms, which completely disappeared 15 days after surgery. Postoperative courses of the other 3 patients (Cases 1, 3, and 4) were uneventful, and all patients were discharged within 20 days after surgery. All patients returned to normal daily life, and no ischemic attack occurred during the follow-up period.
Representative Case 4:
A 34-year-old female presented with crescendo transient motor weakness in her left upper extremity. Initial MR imaging revealed slight chronic ischemic changes in the right cerebral hemisphere (Fig. 1A) . Cerebral angiography showed right-side dominant steno-occlusive changes (Fig. 1B, C) . Preoperative SPECT showed slightly decreased CBF (Fig. 2) and significantly impaired CVR in the right middle cerebral artery territory (not shown). Physical examination revealed bilateral exophthalmos and goiter. Hightiter thyroid-stimulating hormone receptor antibodies were detected and thyroid function tests revealed thyrotoxicosis ( Table 2 ). The patient was diagnosed with Graves' disease by an endocrinologist. The frequency of the TIAs gradually decreased during 2 months treatment with thiamazole. Right STA-MCA anastomosis with EDMS and dural pedicle insertion was performed when the patient was euthyroid. Euthyroid was maintained through perioperative period by anti-thyroid treatment. Postoperative SPECT on days 1 and 7 revealed increased CBF in the right cerebral hemisphere (Fig.  2) . Her blood pressure was strictly controlled between 100 and 140 mmHg to prevent symptomatic cerebral hyperperfusion and cerebral ischemia until discharge. Postoperative MR imaging on days 2 and 8 showed no ischemic or hemorrhagic complications with the patent STA-MCA anastomosis (Fig.  3) . The patient was discharged 11 days after surgery, and the ischemic attack never recurred after discharge.
Discussion
The mechanisms underlying the rare combination of moyamoya vasculopathy and Graves' disease remain undetermined. Hereditary and immunogenic inflammatory factors have been implicated in the etiology of moyamoya disease. Histological analysis of intracranial vessels in moyamoya disease has revealed subendothelial fibrous tissue occluding the vascular lumen, intimal thickening, and smooth muscle cell proliferation, and the presence of macrophages and T cells. 11) The cellular proliferation and vascular dysregulation in moyamoya disease and immunologic stimulation of the thyroid in Graves' disease may have a common pathogenic link involving T-cell dysregulation. 17, 19) In addition to these mechanical vascular abnormalities, excessive thyroid hormones may affect cerebral metabolism, cerebral oxygen consumption, cerebral hemodynamics, and cerebrovascular autoregulation, which may be triggers of the cerebral ischemic event. 7, 9, 10, 19) The effectiveness of simple antithyroid therapy for cerebral ischemic symptoms might indirectly prove these mechanisms. Further study is required to obtain more evidence of the relationship between genetic and immunogenic backgrounds for these associated conditions.
We treat symptomatic patients with moyamoya disease by STA-MCA anastomosis with EDMS and dural pedicle insertion. We applied this treatment strategy to our patients with moyamoya syndrome associated with Graves' disease, and successfully performed revascularization. Whether the present cases should be simply recognized as a symptomatic group remains unclear, because the cerebral ischemic symptoms were relieved by antithyroid treatment. A total of 23 cases including Neurol Med Chir (Tokyo) 50, November, 2010
Moyamoya Syndrome Associated With Graves' Disease the present cases of moyamoya vasculopathy associated with Graves' disease have been described (Table 3) . [5] [6] [7] 9, 10, 12, 13, 16, [19] [20] [21] Interestingly, most of these cases were thyrotoxic when the cerebral ischemic symptoms developed. Thirteen of these patients were successfully treated with antithyroid therapy followed by revascularization surgery. In contrast, ischemic symptoms were successfully controlled only with antithyroid therapy in some patients, although the long-term outcomes after the medical treatment were unclear. 9, [19] [20] [21] The overall relapse rate of Graves' disease after effective antithyroid therapy is as high as 50%. 15) Relapse of the hyperthyroidism would affect the remission of the cerebral ischemic symptoms. Indeed, 2 cases of this study (Cases 1 and 3) were admitted with recurrent hyperthyroid state during medical treatment for Graves' disease. Moreover, atherosclerotic changes of the cerebral blood vessels with aging facilitate decreased CBF, because most of the cases are adultonset moyamoya syndrome. Therefore, prophylactic revascularization for moyamoya vasculopathy with Graves' disease to reduce the potential risk of cerebral ischemic injury can be justified, even if the patients are relieved from ischemic symptoms after antithyroid therapy. The effects of presurgical antithyroid therapy on CBF and CVR capacities may need to be investigated to determine the surgical indications. The major premise for revascularization surgery is optimal remission of hyperthyroidism throughout the perioperative period. Nine previous patients were surgically treated after medical therapy for hyperthyroidism, of whom one developed postoperative ischemic brain injury. 7) In this series, revascularization was performed without remission of thyrotoxicosis. We restarted administration of antithyroid agent from the day after surgery to maintain the euthyroid state, and no patient suffered postoperative ischemic complication. There is little evidence for the effectiveness of presurgical usage of antiplatelet combined with antithyroid agents for the prevention of cerebral ischemia. Careful administration of antiplatelet agent would be required, considering the inclusion of hemorrhagic onset cases in our series (Case 1). Moyamoya syndrome associated with Graves' disease in children is rare, probably due to the rarity of Graves' disease in children. The need for surgical H. Endo et al.
treatment for these young patients should be carefully investigated because of the worse prognosis for younger patients with moyamoya disease. 8) We performed cerebrovascular reconstruction surgery for moyamoya disease, focusing on the cerebral hemodynamics in the early postoperative period. 2, 3) Based on our previous studies, postoperative cerebral hyperperfusion is a potential risk of direct revascularization surgery for moyamoya disease. 2,3) Furthermore, we rarely experienced patients with delayed intracerebral hemorrhage caused by postoperative hyperperfusion. 4) In the present study, postoperative SPECT of all 4 patients showed increased CBF in the operated hemisphere compared with preoperative SPECT. One patient (Case 2) developed symptomatic hyperperfusion, which was improved by intensive blood pressure control, which seemed to suggest that the postoperative cerebral hemodynamics of moyamoya syndrome associated with Graves' disease vary similarly to pure moyamoya disease. Therefore, postoperative blood pressure control to avoid both symptomatic ischemia and hyperperfusion would be desirable in addition to perioperative maintenance of the euthyroid state. In the present study, postoperative cerebral hemodynamics and patency of the STA-MCA anastomosis were manifested during early postoperative period. However, long-term patency of the revascularization, especially of the indirect bypass, for moyamoya syndrome associated with Graves' disease is unknown. The development of collateral vessels via the temporal muscle flap as well as patent STA bypass were angiographically confirmed 6 months after surgery. 13) Lengthy follow up by MR angiography and SPECT are required for the present cases to assess the long-term effectiveness of revascularization surgery for this entity.
Cerebrovascular reconstruction surgery is a successful treatment option for moyamoya syndrome associated with Graves' disease. Timing of surgery during the euthyroid state and perioperative management considering thyroid function and cerebral hemodynamic change are the keys to successful surgical treatment.
